Skip to content

Efficacy of Breast Milk Expressed and Sucrose in Procedural Pain in Preterm

Efficacy of Breast Milk Expressed Versus Sucrose Relief Procedural Pain of Venipuncture in Preterm.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02133716
Acronym
LACTEET
Enrollment
54
Registered
2014-05-08
Start date
2013-10-31
Completion date
2014-10-31
Last updated
2015-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding, Human Milk, Pain, Premature Infant

Keywords

pain, premature infant, sucrose, breastfeeding, expressed breast milk, PIPP

Brief summary

The aim of this study is to assess the non-inferiority of non- pharmacological breast milk expressed versus oral sucrose in relief procedural pain of venipuncture in preterm neonates. This is an experimental comparative study of non-inferiority randomized crossover, to be performed in Neonatal units of hospitals in the Community of Madrid. The 54 pair of preterm that after the selection criteria are included in the study, they performed the randomization of the sequence and breast milk expressed receive oral or 24% sucrose. The doses administered are: 0.1ml preterm less than 27 weeks corrected gestational age (CGA), 0.25 ml for infants 27 to 31 weeks CGA and 0.5 ml for infants of 32-37 weeks. Both groups will be accompanied by non-nutritive sucking and swaddling and administered two minutes prior to venipuncture. The outcome variable, pain, will be determined by the scale Premature Infant Pain Profile (PIPP) and by percent of cry. Data for the primary objective was analysed per intention to treat. This study was approved by local ethical committee.

Interventions

OTHERexpressed breast milk

The administration will be by direct instillation feeding syringe (maximum capacity 1ml) in the front of the mouth of the infant and accompanied throughout the administration of non-nutritive sucking (pacifier) and manual containing both sucrose treatment oral, as in the oral expressed breastmilk. A single dose prior to venipuncture of expressed breast milk given two minutes in the sequence and then will proceed to the venipuncture care nurse responsible for the child, accompanied at all times provided the technical permitted with non-nutritive sucking and containment.

BEHAVIORALsucrose 24% oral

The administration will be by direct instillation feeding syringe (maximum capacity 1ml) in the front of the mouth of the infant and accompanied throughout the administration of non-nutritive sucking (pacifier) and manual containing both sucrose treatment oral, as in the oral expressed breastmilk. A single dose prior to venipuncture of oral sucrose 24% given two minutes in the sequence and then will proceed to the venipuncture care nurse responsible for the child, accompanied at all times provided the technical permitted with non-nutritive sucking and containment.

Sponsors

Hospital General Universitario Gregorio Marañon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Weeks to 37 Weeks
Healthy volunteers
No

Inclusion criteria

* Preterm neonates. * Weight less than 2500 grams. * Feed breastfeeding (exclusive or not) or can obtain weight expressed breastmilk . * Be informed and consent to the parents of those infants previously requested.

Exclusion criteria

* Maternal use of opioids or insulin-depent * infants with invasive artificial respiration * infants with major congenital anomalies * infants with grade II or IV intraventricular hemorrhage or strokes * receiving parental sedatives or vasoactive drugs * infants with necrotizing enterocolitis * with surgical interventions * infants in absolute diet * infants with abstinence syndrome

Design outcomes

Primary

MeasureTime frameDescription
Pain neonatalMidpoint analysis will be conducted when half the patients are recruited, at an estimated time of 12 monthsThe pain neonatal will be determined by the scale Premature Infant Pain Profile (PIPP). The PIPP scale is a multidimensional measure developed to assess pain in preterm and term infants. It consists of three behavioral indicators (facial actions: philtrum, frowning, clenched eyes), two physiological indicators (heart rate and oxygen saturation) and two measures of development (gestational age and behavioral state). Each pointer may take four values on a scale from 0 to 3, which is subsequently added to an overall score. The score range from 0 (no pain or the presence of minimal pain) to 21 (maximum pain) in preterm. PIPP score was evaluated at 30 seconds after venopuncture Both the validity and reliability of this scale have been studied and proven in various studies. The PIPP scale will it be monitored by skilled and experienced nurses in neonatal care.

Secondary

MeasureTime frameDescription
Percentage of cryingMidpoint analysis will be conducted when half the patients are recruited, at an estimated time of 12 monthsRelationship between duration procedure venipuncture and the time or duration of crying(from beginning to cry until terminated.)

Other

MeasureTime frameDescription
Number of attemptsMidpoint analysis will be conducted when half the patients are recruited, at an estimated time of 12 months.Number of attempts during the venopuncture

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026